Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium perfringens

Department of Veterinary Science and Microbiology, University of Arizona, 1117 E. Lowell Street, Tucson, AZ 85721, United States.
Veterinary Microbiology (Impact Factor: 2.73). 01/2009; 133(1-2):92-7. DOI: 10.1016/j.vetmic.2008.06.001
Source: PubMed

ABSTRACT Necrotic enteritis (NE) in poultry has re-emerged as a concern for poultry producers, due in part to banning, by many countries, of the use of antimicrobial growth promoters in feeds. This re-emergence has led to a search for alternative methods for control of the disease, particularly vaccination. The objective of this work was to determine if vaccination of broiler chicks with recombinant alpha toxin protected against experimental challenge. Broiler chicks were vaccinated subcutaneously at 5 and 15 days of age, followed 10 days later by challenge with Clostridium perfringens. Birds were challenged twice daily on 4 consecutive days by mixing C. perfringens cultures with feed (three parts culture: four parts feed). Non-vaccinated birds challenged with C. perfringens developed NE at the rate of 87.8%, while only 54.9% of vaccinated birds developed lesions. In addition, non-vaccinated birds had lesion scores averaging 2.37, while average scores in vaccinated birds were 1.35. Vaccination produced an antibody response, with post-vaccination anti-alpha toxin IgG (IgY) titers in vaccinated birds more than 5-fold greater than in non-vaccinated birds. After challenge, vaccinated birds had average IgG (IgY) titers>15-fold higher than those in non-vaccinated birds. These results suggest that alpha toxin may serve as an effective immunogen, and, as such, may play a role in pathogenesis.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study was conducted to investigate the effects of in ovo administration of selenium (Se) incorporated into hydrolyzed soybean protein (B-Taxim [BT]) on protection against experimental avian necrotic enteritis (NE). Broiler eggs were injected with either 100 μl of PBS alone (BT0), or 20 or 40 μg/egg of BT in PBS (BT20, BT40) at 18 days of embryogenesis. On day 14 post-hatch, the chickens were uninfected or orally infected with 1.0 × 104 oocysts of Eimeria maxima (E. maxima). On day 18 post-hatch, E. maxima-infected chickens were orally infected with 1.0 × 109 CFU of Clostridium perfringens (C. perfringens). Compared with untreated and infected BT0 controls, BT20 and/or BT40 birds showed increased body weights, decreased fecal shedding of E. maxima oocysts, lower serum α-toxin and NetB levels, increased levels of serum antibodies against C. perfringens α-toxin and NetB toxin, decreased levels of serum malondialdehyde, reduced serum catalase and superoxide dismutase catalytic activities, and increased intestinal levels of gene transcripts encoding interleukin (IL)-1β, IL-6, IL-8, and peroxiredoxin-6, but decreased levels of transcripts for catalase and glutathione peroxidase. Interestingly, transcript levels for inducible nitric oxide synthase and paraoxonase/arylesterase 2 were decreased in the BT20 group and increased in the BT40 group, compared with BT0 controls. These results indicate that in ovo administration of broiler chickens with a Se-containing protein hydrolysate enhanced protection against experimental NE possibly by altering the expression of proinflammatory and anti-oxidant genes and their downstream pathways.
    Veterinary Parasitology 10/2014; 206(3-4). DOI:10.1016/j.vetpar.2014.10.025 · 2.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Direct-fed microbials (DFMs), also known as probiotics, have been successfully used to improve the balance of gut microbiota. Spores of Bacillus subtilis, have been used as DFMs for food animals and humans and our previous studies showed that dietary supplementation of broiler chickens with a B. subtilis DFM from hatch enhanced innate immunity and improved protection against avian coccidiosis. In two experiments, we investigated the effects of dietary B. subtilis-based DFM on growth performance and host humoral immune response to Eimeria spp. and Clostridium perfringens, and evaluated B. subtilis-induced global gene expression changes in broiler chickens. Day-old broiler chickens were fed diets with or without DFMs for 28 days starting from hatch. At 14 and 28 days post-hatch, broiler chickens fed the DFM-enriched diet gained significantly more weight (P<0.05) compared with the control diet-fed chickens. Broiler chickens fed diet containing DFM exhibited a significant decrease (P=0.033) in Eimeria- and C. perfringens necrotic enteritis B-like (NetB) toxin-specific serum antibodies compared with those fed a control diet at day 28. The levels of transcripts encoding interleukin (IL) 1β, IL12 and interferon-γ were greater (P=0.004) in the DFM-fed chickens compared with the control chickens. In order to better understand B. subtilis-induced molecular changes associated with improved innate immunity, mRNA was isolated from mid-intestine of DFM-fed chickens for global microarray analysis. Dietary DFMs induced considerable changes in transcriptional expression in intestine, and biofunctional analysis identified 37 genes related with “Inflammatory Response”. These results indicate that dietary B. subtilis DFM is an effective growth-promoting dietary supplement to increase growth and augment innate immune response in broiler chickens. Further study is needed to investigate the mechanism mediated by dietary DFMs to enhance protective innate immunity in a disease model (i.e., necrotic enteritis) which causes considerable economic impact in the poultry industry worldwide.
    Animal Feed Science and Technology 02/2015; 200:76-85. DOI:10.1016/j.anifeedsci.2014.12.006 · 2.09 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The causative pathogen of necrotic enteritis is Gram-positive bacterium Clostridium perfringens. Its main cell wall component, peptidoglycan (PGN), can be recognized by Toll-like receptor 2 and nucleotide-binding oligomerization domain (NOD). Consequently, immune response is initiated via activation of nuclear factor kappa B (NF- κB) signaling pathway. An in vitro study was conducted to investigate chicken intestinal inflammatory responses to C. perfringens type A and one of its virulence factors, α-toxin. In primary intestinal epithelial cells, C. perfringens as well as commercially available PGN and α-toxin challenge up-regulated mRNA expression of interleukin (IL)-6, IL-8 and inducible nitric oxide synthase (iNOS) with a dosage-dependent manner at 3 h post infection (p.i.) (P ≤ 0.001). Time-course effects of three stimulators at high concentration were further examined. C. perfringens infection elevated IL-6, IL-8 and iNOS levels from 1 h to 9 h p.i., while PGN treatment increased IL-6 and IL-8 expression at 1 h and 3 h p.i. (P < 0.05). Bacterial and PGN treatments induced NOD1 expression at 6 h p.i. and only bacterial infection boosted NF- κB p65 expression at 6 h and 9 h p.i. (P < 0.05). α-Toxin treatment up-regulated IL-6 and IL-8 expression along infection, as well as iNOS, TNF- α and NF- κB p65 expression at later hours p.i. (P < 0.05). In conclusion, both C. perfringens and α-toxin challenge induced intense cytokine expression associated with NF- κB activation in chicken intestinal epithelial cells. The receptors for the recognition of PGN component of C. perfringens need further investigation.
    Avian Pathology 01/2015; 44(2):1-37. DOI:10.1080/03079457.2015.1005573 · 2.04 Impact Factor


Available from
Jul 10, 2014